Constellation Pharma
AcquiredCambridge, US · 5 known investors
Founders & leadership
MR
Michael R. CooperExecutive
JE
James E. AudiaExecutive
KD
Keith DionneExecutive
MJ
Matthias JaffeExecutive
MA
Mark A. GoldsmithExecutive
TM
Tom ManiatisNamed on SEC filing
SP
Steven PaulNamed on SEC filing
Board
AE
Anthony EvninBoard director
RT
DG
David GoeddelBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$249.1M disclosed across 5 rounds · 2014–2019
▶$65MraisedOct 2019 · 11 investors · BiotechnologyRule 506(b)
▶$65MraisedOct 2019 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jigar RaythathaExecutive Officer, Director
- Anthony EvninDirector
- Mark A. GoldsmithDirector
- Robert TepperDirector
- James E. AudiaDirector
- Patrick TrojerExecutive Officer
- Elizabeth G. TrehuDirector
- Steven HoerterDirector
- Scott BraunsteinDirector
- Adrian SenderowiczExecutive Officer
- Karen ValentineExecutive Officer
- Emma ReeveExecutive Officer
- Offering amount
- $65M
- Amount sold
- $65M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$99MraisedApr 2018 · 30 investors · BiotechnologyRule 506(b)
▶$99MraisedApr 2018 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jigar RaythathaExecutive Officer, Director
- Anthony EvninDirector
- Robert TepperDirector
- James E. AudiaDirector
- Emma ReeveExecutive Officer
- Mark A. GoldsmithDirector
- Peter SvennilsonDirector
- Offering amount
- $100M
- Amount sold
- $99M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.3MraisedSep 2016 · 17 investors · BiotechnologyRule 506(b)
▶$24.3MraisedSep 2016 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert TepperDirector
- Anthony EvninDirector
- James E. AudiaExecutive Officer
- Michael R. CooperExecutive Officer
- Matthias JaffeExecutive Officer
- Peter SvennilsonDirector
- Mark A. GoldsmithExecutive Officer, Director
- Tom ManiatisDirector
- Offering amount
- $24.3M
- Amount sold
- $24.3M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$55.8MraisedDec 2015 · 22 investors · BiotechnologyRule 506(b)
▶$55.8MraisedDec 2015 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tom ManiatisDirector
- Michael R. CooperExecutive Officer
- Anthony EvninDirector
- James E. AudiaExecutive Officer
- Keith DionneExecutive Officer, Director
- Matthias JaffeExecutive Officer
- Mark A. GoldsmithDirector
- Robert TepperDirector
- David GoeddelDirector
- Offering amount
- $55.8M
- Amount sold
- $55.8M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedAug 2014 · 8 investors · BiotechnologyRule 506(b)
▶$5MraisedAug 2014 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert TepperDirector
- David GoeddelDirector
- Steven PaulDirector
- Michael R. CooperExecutive Officer
- Keith DionneExecutive Officer, Director
- Matthias JaffeExecutive Officer
- Mark A. GoldsmithDirector
- James E. AudiaExecutive Officer
- Tom ManiatisDirector
- Anthony EvninDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Constellation Pharma's investors?
- Constellation Pharma's investors include Avoro Capital Advisors, Bain Capital Life Sciences, Venrock, The Column Group, Third Rock Ventures.
- How much funding has Constellation Pharma raised?
- Constellation Pharma has disclosed $249.1M raised across 5 rounds.
- Where is Constellation Pharma headquartered?
- Constellation Pharma is headquartered in Cambridge, US.